May 23, 2026 by Anthony Di Pizio1 Spectacular Growth Stock to Buy Before It Soars by as Much as 124%, According to Wall StreetThis stock looks so attractively valued that I recently bought some myself.
May 23, 2026 by Reuben Gregg BrewerBrent Crude Is Up 85% Since January. OXY, XOM, and CVX Are Playing It Very Differently.Why didn't Occidental Petroleum, ExxonMobil, and Chevron do better in the first quarter?
May 23, 2026 by Daniel SparksTarget Just Posted Its First Sales Growth in 5 Quarters. So Why Did the Stock Drop Anyway?A strong sales number and a raised full-year outlook still couldn't keep the big-box retailer's shares from sliding after its latest report.
May 23, 2026 by Seena HassounaA Modest Trim From Fairholme — Here's why JOE Is Still Worth a LookThis Northwest Florida real estate developer reported a notable insider sale amid ongoing revenue growth from its diversified operations.
May 23, 2026 by David DierkingIs XLE the Right Fit for Your Portfolio Before Summer?Energy stocks have cooled off substantially in Q2 and are getting whipsawed around by the Iran war.
May 23, 2026 by Jonathan PoncianoThis Payments Stock Is Down 50%. One Fund Sold a $63 Million Stake Last QuarterShift4 Payments delivers integrated payment and software solutions to U.S. businesses across retail, hospitality, and eCommerce sectors.
May 23, 2026 by Anthony Di Pizio1 Spectacular Growth Stock to Buy Before It Soars by as Much as 124%, According to Wall StreetThis stock looks so attractively valued that I recently bought some myself.
May 23, 2026 by Jonathan PoncianoWhat This Fund's $24 Million monday.com Sale Could Signal After a 73% Stock Dropmonday.com delivers cloud-based workflow solutions to a global client base through a scalable SaaS platform and subscription model.
May 23, 2026 by Reuben Gregg BrewerBrent Crude Is Up 85% Since January. OXY, XOM, and CVX Are Playing It Very Differently.Why didn't Occidental Petroleum, ExxonMobil, and Chevron do better in the first quarter?
May 23, 2026 by Seena HassounaPhibro's CEO transition puts this insider sale in contextThis animal health company, serving global livestock producers, reported a notable insider sale in its latest SEC filing.
May 23, 2026 by Daniel SparksTarget Just Posted Its First Sales Growth in 5 Quarters. So Why Did the Stock Drop Anyway?A strong sales number and a raised full-year outlook still couldn't keep the big-box retailer's shares from sliding after its latest report.
May 23, 2026 by Geoffrey Seiler2 Tech Stocks Down 25% That Smart Money Is Buying Hand Over Fist Right NowHedge funds were loading up on Microsoft and Uber shares in Q1.
May 23, 2026 by Jonathan PoncianoWhat This Fund's $20 Million Sale Says About a Packaging Giant Facing a Turnaround TestGraphic Packaging supplies fiber-based packaging for global consumer and foodservice brands, with a focus on sustainability and scale.
May 23, 2026 by Anthony Di Pizio1 Unstoppable Cryptocurrency to Buy Before It Soars 930%, According to Cathie Wood's Ark InvestArk Invest believes this cryptocurrency will amass a market cap of $16 trillion by 2030.
May 23, 2026 by Jonathan PoncianoWhat to Know About This Fund's $85 Million Lionsgate Buy During a Breakout QuarterLionsgate Studios leverages a vast film and TV library to serve global broadcasters, streamers, and distributors with premium content.
May 23, 2026 by Steven PorrelloDespite Its Recent Partnership with Apple, MP Materials Stock Is Down. Here's Why.MP Materials is trading flat on the year. With major partnerships backing it, why isn't this rare-earth stock soaring?
May 23, 2026 by Jeff SiegelIs Viking Therapeutics a Top Takeover Target?Viking's strong obesity drug data continues fueling acquisition speculation.
May 23, 2026 by Jonathan PoncianoWhat to Know About This Fund's $10 Million Nektar Bet Ahead of a Key Phase 3 LaunchBiotech firm Nektar Therapeutics advances a pipeline of immunology and oncology candidates through research-driven collaborations.
May 23, 2026 by Jonathan PoncianoThis Healthcare Investor Added $43 Million to a Genomics Leader Growing Volume 34%GeneDx Holdings delivers AI-powered clinical and genomic data analysis for healthcare providers seeking precision medicine solutions.
May 23, 2026 by Courtney CarlsenIs Goldman Sachs a Better Buy After Earnings Than Wall Street Thinks?Capital markets activity is booming, and Goldman Sachs is reaping the benefits.
May 23, 2026 by Adam LevyBillionaire Philippe Laffont Trimmed 8 of His Fund's Top 10 Positions Last Quarter. Here's What the Other 2 Have in Common.The growth investor is shifting his portfolio in favor of a key artificial intelligence segment.
May 23, 2026 by Katie BrockmanVOO vs. IVV: Which Popular S&P 500 ETF Is the Better Buy for Investors?With identical fees and returns, these two S&P 500 ETFs differ in a few minor ways that could make a difference for investors.
May 23, 2026 by Harsh ChauhanIntel Has Soared 225% in 2026. Here's Where the AI Stock Could Be By the End of 2028Intel's stunning rally in 2026 has made the stock really expensive.
